San Francisco, CA (PRWEB) February 03, 2012
The Scleroderma Research Foundation (SRF) is presenting the next webinar in their series for people living with scleroderma and others directly or indirectly affected by the disease. The free Webinar will educate viewers on the tools used by investigators to propel research forward as well as what new research findings are on the horizon.
“Scleroderma” literally means “hard skin,” but oftentimes the illness affects internal organs with life-threatening consequences. Approximately four out of five patients are women with onset between the ages of 20 and 50, but the disease also strikes men and children across all ages and ethnic boundaries.
The 2012 Webinar series is for patients, physicians, family members, friends and others looking to educate themselves on current treatments, recent research discoveries, clinical trials and other aspects of managing scleroderma. Guest speakers include experts in the research community and leading physicians who treat scleroderma patients.
On February 10, Antonios Aliprantis, MD, PhD will present “Exploring the Scleroderma Research Toolbox.” Dr. Aliprantis, an Assistant Professor of Medicine in the Rheumatology Division at Brigham and Women's Hospital (BWH) and Harvard Medical School, will take participants on a tour inside the toolbox researchers use to better understand this complex disease. He has been working with the SRF since 2006 and, along with Dr. Laurie Glimcher, is the recipient of the Foundation's Actelion Research Award made possible by a generous grant from Actelion Pharmaceuticals. Dr. Aliprantis is also the recipient of the American Society for Clinical Investigation Young Investigator Award.
Each free Webinar will last approximately one hour and include a question and answer session.
Friday, February 10, 2012 from 9:00 – 10:00 a.m. PST. The Webinar will be available for later viewing on the SRF website.
Register online at http://www.sclerodermaRESEARCH.org.
About Scleroderma Research Foundation:
The Scleroderma Research Foundation is the nation’s leading nonprofit investor in scleroderma research. It was founded in San Francisco in 1987 by scleroderma patient Sharon Monsky who lost her battle to the disease in 2002. Monsky’s legacy lives on through the organization she founded, chaired by Luke Evnin, Ph.D., managing partner of MPM Capital, one of the world’s largest dedicated investors in life sciences.
The Foundation’s collaborative approach is enabling scientists from leading institutions to work together and develop an understanding of how scleroderma begins, how it progresses and what can be done to slow, halt or reverse the disease process.